Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Receives Consensus Recommendation of “Moderate Buy” from Analysts
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the thirty research firms that are presently covering the company, Marketbeat.com reports. Fourteen analysts have rated the stock with a hold recommendation, fifteen have given a buy recommendation and one has given a strong buy recommendation to the […]
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the thirty research firms that are presently covering the company, Marketbeat.com reports. Fourteen analysts have rated the stock with a hold recommendation, fifteen have given a buy recommendation and one has given a strong buy recommendation to the […]
